Risk factors for residual disease at re-TUR in a large cohort of T1G3 patients.
Pisano F, Gontero P, Sylvester R, Joniau S, Serretta V, Larré S, Di Stasi S, van Rhijn B, Witjes A, Grotenhuis A, Colombo R, Briganti A, Babjuk M, Soukup V, Malmstrom PU, Irani J, Malats N, Baniel J, Mano R, Cai T, Cha E, Ardelt P, Varkarakis J, Bartoletti R, Dalbagni G, Shariat SF, Xylinas E, Karnes RJ, Palou J.
Pisano F, et al. Among authors: varkarakis j.
Actas Urol Esp (Engl Ed). 2021 Jul-Aug;45(6):473-478. doi: 10.1016/j.acuroe.2020.08.014. Epub 2021 Jun 17.
Actas Urol Esp (Engl Ed). 2021.
PMID: 34147426
English, Spanish.